FDA Authorizes Use of Monoclonal Antibody Treatment for COVID-19
IV infusion of casirivimab and imdevimab authorized for treatment of mild-to-moderate COVID-19
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.